PRIMITY BIO
Primity Bio was founded in 2010 with the goal of bringing innovative flow cytometry platforms to biopharma for use throughout the drug discovery process, from lead selection through clinical trial sample analysis. Its discovery unit provides specialized platforms that include profiling of cell surface and intracellular signaling proteins, high-speed cell sorting by FACS, and deep interrogation of drug mechanism of action. Primity’s clinical unit delivers fully customized and complex immunophenotyping, receptor occupancy, and cell signaling assays of clinical samples for exploratory pharmacodynamic analysis. Primity also offers analysis of pre-clinical and clinical samples by CyTOF (mass cytometry) which expands the number of measurable biomarkers per sample to over 35.
PRIMITY BIO
Industry:
Biopharma Biotechnology Life Science
Founded:
2010-01-01
Address:
Fremont, California, United States
Country:
United States
Website Url:
http://www.primitybio.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving SPF Mobile Non Scaleable Content Google Apps For Business Pound Sterling Japanese Yen Java EE Digital Ocean Google No Translate Google DNS
Similar Organizations
ALL Chemistry Inc.
ALL Chemistry Inc. is your reliable partner for contract research and advanced synthesis and analysis.
PCI Pharma Services
PCI Pharma Services is a provider of outsourced services to the global pharmaceutical market.
Probius
Probius specializes in providing services from biomarker discovery to quantification.
TissueArray.Com
TissueArray.Com specializes in development, sales, and biotechnology services.
Founder
Official Site Inspections
http://www.primitybio.com
- Host name: hosting13.parkour3.com
- IP address: 159.89.115.187
- Location: Toronto Canada
- Latitude: 43.6547
- Longitude: -79.3623
- Timezone: America/Toronto
- Postal: M5A
More informations about "Primity Bio"
Primity Bio Company Profile | Management and Employees List
Primity Bio Profile and History. Primity Bio was founded in 2010 with the goal of bringing innovative flow cytometry platforms to biopharma for use throughout the drug discovery …See details»
Primity Bio Company Profile 2024: Valuation, Investors ... - PitchBook
Primity Bio General Information Description. Developer of a next-generation drug discovery assay platform. The company's platform utilizes single cell analysis to deliver pathway phenotyping, …See details»
Primity Bio, Inc. Company Profile | Fremont, CA | Competitors ...
Primity Bio, Inc. D&B Business Directory HOME / BUSINESS DIRECTORY / PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES / SCIENTIFIC RESEARCH AND …See details»
About us - CellCarta
He received his graduate training in immunology and malaria with Dr. Paul-Henri Lambert at the World Health Organization, Geneva, Switzerland from 1978-79, and his post-doctoral training …See details»
Primity Bio, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Primity Bio, Inc. with its drug pipeline, therapeutic area, technology platform, 3 literature.See details»
Primity Bio Inc - Company Profile and News - Bloomberg Markets
Company profile page for Primity Bio Inc including stock price, company news, executives, board members, and contact informationSee details»
Primity Bio - Contacts, Employees, Board Members, Advisors
Primity Bio is a specialised provider of biomarker and immune monitoring services.See details»
Primity Bio - Craft
Primity Bio is a company that provides solutions for target-based discovery and analysis of cell lines, primary cells, and clinical samples. It specializes in CyTOF mass cytometry, cell sorting, …See details»
Primity Bio - Crunchbase
Primity Bio is a specialised provider of biomarker and immune monitoring services.See details»
Caprion Biosciences Expands its Biomarker and …
Aug 21, 2018 Primity Bio was founded in 2010 with the goal of bringing innovative flow cytometry platforms to biopharma for use throughout the drug discovery process, from lead selection through clinical trial ...See details»
Annual Report on Primity Bio's Revenue, Growth, SWOT Analysis ...
Determine whether Primity Bio grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof …See details»
Primity Bio - Products, Competitors, Financials, Employees ...
Primity Bio is a provider of biomarker and immune monitoring services. Use the CB Insights Platform to explore Primity Bio's full profile. Primity Bio - Products, Competitors, Financials, …See details»
Primity Bio CEO and Key Executive Team | Craft.co
Primity Bio's Chief Executive Officer is Martin Leblanc. Other executives include Nick Wright, President and Global Chief Operating Officer; Todd Chermak, Chief Regulatory and …See details»
Primity Bio - Company Profile - Tracxn
Oct 24, 2024 Primity Bio ranks 19th among 39 active competitors. 13 of its competitors are funded while 6 have exited. Overall, Primity Bio and its competitors have raised over $271M in …See details»
PRIMITY, INC. | VentureRadar
Similar Companies: Protea Biosciences Group USA n/a Protea Biosciences is an innovative bioanalytics technology organization offering Mass Spectrometry Imaging and LC-MS services …See details»
Caprion Acquires Primity Bio, Adding to Immunology and …
Aug 21, 2018 Caprion Biosciences said today it has acquired Primity Bio for an undisclosed price, in a deal designed to expand the buyer’s immunology and molecular profiling service …See details»
Caprion acquires Primity Bio - 2018-08-21 - Crunchbase
Aug 21, 2018 Primity Bio Primity Bio is a specialised provider of biomarker and immune monitoring services. Acquiring Organization: Caprion CellCarta's highly trained, multi …See details»
Caprion Biosciences Expands its Biomarker and Immune …
Aug 21, 2018 Caprion Biosciences announced today that the company acquired Primity Bio Inc., a specialised provider of biomarker and immune monitoring services located in Fremont, …See details»
Caprion Acquires Primity Bio - GenomeWeb
Aug 21, 2018 "The acquisition of Primity Bio provides us access to highly complementary and well-differentiated biomarker and immune monitoring services while considerably expanding …See details»